MAI Capital Management - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$413,577
-4.6%
397,670
+29.3%
0.01%0.0%
Q2 2023$433,674
-28.1%
307,570
-18.9%
0.01%
-40.0%
Q1 2023$603,354
-3.2%
379,468
-11.1%
0.01%0.0%
Q4 2022$623,297
-77.1%
426,916
-33.0%
0.01%
-80.4%
Q3 2022$2,723,000
+8.3%
637,641
-1.6%
0.05%
+6.2%
Q2 2022$2,514,000
+38.7%
647,950
+70.2%
0.05%
+54.8%
Q1 2022$1,813,000380,7880.03%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders